原发性肝血管肉瘤的CT检查影像学特征

CT characteristics of primary hepatic angiosarcoma

  • 摘要: 目的:总结原发性肝血管肉瘤的CT检查影像学特征。
    方法:采用回顾性横断面研究方法。收集2006年1月至2017年6月温州市中医院(3例)、温州医科大学附属第二医院(3例)和温州市人民医院(3例)收治的9例原发性肝血管肉瘤患者的临床病理资料。患者检查前禁食8 h,检查时不行腹部加压,采用屏气扫描。扫描范围从膈顶至两肾下极水平。由2位副高职称医师进行图像分析。患者完成术前检查后,根据患者意愿和个体情况选择不进行治疗、手术切除、肝移植或化疗+单克隆抗体靶向治疗。观察指标:(1)CT检查平扫表现。(2)CT检查增强扫描表现。(3)病理学检查结果。(4)随访和生存情况。术后采用门诊、住院及影像学检查方式进行随访,了解患者肿瘤复发及病情稳定情况等,随访时间截至2017年12月。
    结果:(1)CT检查平扫情况:9例患者肿瘤位于肝左叶3例,肝右叶6例,均为单发肿瘤,其中肿瘤呈圆形5例,呈椭圆形3例,呈斑片状1例。肿瘤最大直径为5.8~16.0 cm,平均最大直径为10.8 cm,其中肿瘤最大直径>6.0 cm 8例。9例患者肿瘤均呈低密度影,CT值为32~46 HU,平均CT值为41 HU,其中密度均匀3例,密度不均匀6例;肿瘤界限清晰6例,界限不清晰3例;肿瘤坏死囊变4例,肿瘤中心有条片状稍高密度影4例,瘤内见小片状钙化1例。(2)CT检查增强扫描表现:①动脉期:9例患者肿瘤均呈轻、中度不均匀强化,CT值为63~76 HU,平均CT值为68 HU,其中3例肿瘤周边呈小片状或结节状强化,6例肿瘤中心呈斑片状或絮状强化。4例肿瘤中度强化,密度高于正常肝实质;5例肿瘤轻度强化,密度等于和略低于肝实质。②门静脉期:9例患者肿瘤均呈轻、中度持续渐进性强化,密度不均匀,CT值为56~71 HU,平均CT值为63 HU,其中3例肿瘤强化范围扩大,有融合充填趋势;6例肿瘤中心及周边小片状或结节状强化和网格样强化,并向中心充填。2例肿瘤中度强化,密度高于正常肝实质;7例轻度强化,密度等于和略低于肝实质。③延迟期:9例患者均见肿瘤内强化缓慢退出,CT值为50~60 HU,平均CT值为53 HU,其中3例肿瘤周边强化结节密度降低;6例肿瘤强化部分融合并向中心充填,坏死部分无强化。2例肿瘤密度略高于正常肝实质;1例肿瘤密度等于肝实质;6例肿瘤密度略低于肝实质。(3)病理学检查结果:①病理学检查:肿瘤切面呈灰黄、灰褐色,部分区域呈鱼肉状,内部均见出血、坏死。镜下见瘤细胞呈弥漫性增生,肿瘤组织由不规则、相互吻合的血管腔隙组成,沿肝窦间隙浸润性生长;瘤细胞呈梭形、圆形或不规则形;细胞质轻度嗜酸性,细胞核染色质深,长形或不规则形,核仁大小不等。②免疫组织化学染色检测:CD31、CD34强阳性,波形蛋白、Nestine阳性,CK19、肌动蛋白、肌酸激酶阴性。(4)随访和生存情况:9例患者中,3例未治疗患者分别于3个月、6个月和7个月死亡;2例患者行肝切除术后分别于4个月和5个月肿瘤复发并侵犯右肾包膜、膈肌及右胸腔出血致血胸,生存13个月和15个月;2例患者行肝移植后分别于4个月和8个月死于全身广泛转移;2例患者行化疗+单克隆抗体靶向治疗,生存12个月。
    结论:原发性肝血管肉瘤的CT检查具有一定特征性,平扫为不均匀低密度影,增强扫描为肿瘤中央呈小片状、絮状或周边结节状持续性渐进性强化,与周围肝实质分界清晰。

     

    Abstract: Objective:To summarize the computed tomography (CT) characteristics of primary hepatic angiosarcoma (PHA).
    Methods:The retrospective cross-sectional study was conducted. The clinicopathological data of 9 PHA patients who were admitted to the Wenzhou Chinese Medicine Hospital (3 patients), Second Affiliated Hospital of Wenzhou Medical College (3 patients) and Wenzhou People′s Hospital (3 patients) between January 2006 and June 2017 were collected. All 9 patients were fasting 8 hours before CT examination, and received screen scans without abdominal pressure. Scanning area was from dome of diaphragm to lower pole of the kidneys. Two associate senior doctors made images analysis. After preoperative examinations, patients selected whether or not to undergo treatment, resection, liver transplantation or chemotherapy + targeted therapy of monoclonal antibodies. Observation indicators: (1) plain scan appearances of CT; (2) enhanced scan appearances of CT; (3) results of pathological examinations; (4) follow-up and survival situations. Follow-up using outpatient, inpatient and imaging examinations was performed to detect tumor recurrence and stable condition up to December 2017.
    Results: (1) Plain scan appearances of CT: 9 patients showed solitary tumor, and tumors were respectively located in the left lobe (3 cases) and right lobe (6 cases) of the liver, including 5 with round tumors, 3 with oval tumors and 1 with patchy tumor. The maximum diameter of tumor was 5.8-16.0 cm, with an average of 10.8 cm, including maximum diameter > 6.0 cm in 8 patients. Tumors of 9 patients showed low-density shadow, and CT value was 32-46 HU, with an average of 41 HU, including homogeneous density in 3 patients and heterogeneous density in 6 patients; clear tumor boundary in 6 patients and unclear tumor boundary in 3 patients; tumor necrosis and cystolization in 4 patients, slightly strip-shaped high-density shadow in the center of tumor in 4 patients, and small patch-shaped intratumoral calcification in 1 patient. (2) Enhanced scan appearances of CT: ① Arterial phase: tumors of 9 patients showed mild and moderate heterogeneous enhancements, with CT value of 63-76 HU and an average of 68 HU, including small patch-shaped or nodular enhancement in 3 patients and punctate or flocculent enhancement in the center of tumor in 6 patients. Tumors of 4 patients showed moderate enhancements, and tumor density was higher than that of normal liver parenchyma. Tumors of 5 patients showed mild enhancements, and tumor density was equal to or slightly less than that of normal liver parenchyma. ② Portal vein phase: tumors of 9 patients showed mild and moderate, continuous and progressive enhancements, with a heterogeneous density, CT value of 56-71 HU and an average of 63 HU, including extended enhancement region in 3 patients, with a fusion and filling trend; small patch-shaped or nodular and lattice network-shaped enhancements of center and periphery of tumor in 6 patients, showing center filling and enhancement features of hepatic angiosarcoma. Tumors of 2 patients showed moderate enhancements, and tumor density was higher than that of normal liver parenchyma; tumors of 7 patients showed mild enhancements and tumor density was equal to or slightly less than that of normal liver parenchyma. ③ Delayed phase: tumor enhancements of 9 patients slowly seceded, with CT value of 50-60 HU and an average of 53 HU, including density decreasing of periphery of tumor in 3 patients; partial fusion and center filling of enhancements in 6 patients, without enhancement in necrotic area. Tumor density was slightly higher than that of normal liver parenchyma in 2 patients, equal to that of normal liver parenchyma in 1 patient, and slightly less than that of normal liver parenchyma in 6 patients. (3) Results of pathological examinations: ① Pathological examinations: cut surface of tumors showed grayish yellow and drab gray, and parts of surface were fish flesh shape, with internal bleeding and necrosis. Tumors were found in diffuse hyperplasia under microscopy, tumor tissues were made up of irregular and mutual matching lacuna vasorum, with infiltrating growths along hepatic sinus gap; hepatic angiosarcoma cells were spindle, round or irregular; there were slightly eosinophilia cytoplasm and deep chromatin of the nucleus, long-shaped or irregular nucleus, and different sizes of nucleolus. ② Immunohistochemical staining: CD31 and CD34 were strongly positive, vimentin and Nestine were positive, and CK19, actin and creatine kinase were negative. (4) Follow-up and survival situations: of 9 patients, 3 without treatment respectively died at 3, 6 and 7 months; 2 had recurrence at 4 and 5 months after tumor resection, with angiosarcoma invading right renal capsule, diaphragm and right pleural hemorrhage induced to haemothorax, and survived respectively for 13 and 15 months; 2 respectively died of systemic metastasis at 4 and 8 months after liver transplantation; 2 underwent chemotherapy + targeted therapy of monoclonal antibodies, and survived for 12 months.
    Conclusions:CT appearances of PHA have certain characteristics. The plain scans of CT show heterogeneous low-density shadow, and enhanced scans of CT show small patch, punctate or nodular-shaped, continuous and progressive enhancements, with a clear boundary between tumor and liver parenchyma.

     

/

返回文章
返回